S Biomedics Co (XKRX:304360) Long-Term Capital Lease Obligation : ₩624 Mil (As of Mar. 2024)

View and export this data going back to 2023. Start your Free Trial

What is S Biomedics Co Long-Term Capital Lease Obligation?

S Biomedics Co's Long-Term Capital Lease Obligation for the quarter that ended in Mar. 2024 was ₩624 Mil.

S Biomedics Co's quarterly Long-Term Capital Lease Obligation increased from Sep. 2023 (₩812 Mil) to Dec. 2023 (₩825 Mil) but then declined from Dec. 2023 (₩825 Mil) to Mar. 2024 (₩624 Mil).

S Biomedics Co's annual Long-Term Capital Lease Obligation increased from Dec. 2020 (₩450 Mil) to Dec. 2021 (₩521 Mil) but then declined from Dec. 2021 (₩521 Mil) to Dec. 2022 (₩207 Mil).

S Biomedics Co Long-Term Capital Lease Obligation Historical Data

The historical data trend for S Biomedics Co's Long-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

S Biomedics Co Long-Term Capital Lease Obligation Chart

S Biomedics Co Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Long-Term Capital Lease Obligation

Get a 7-Day Free Trial

867.93

449.83

520.66

206.79

S Biomedics Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Long-Term Capital Lease Obligation	Get a 7-Day Free Trial															181.27	165.40	812.27	824.86	624.46

S Biomedics Co (XKRX:304360) Long-Term Capital Lease Obligation Explanation

Long-Term Capital Lease Obligation are the amount due for long-term asset lease agreements that are nearly equivalent to asset purchases. Capital lease obligations are installment payments that constitute a payment of principal plus interest for the capital lease. The Short-Term Capital Lease Obligation is the portion of a Long-Term Capital Lease Obligation that is due over the next year.

Under US Generally Accepted Accounting Principles (GAAP), a capital lease is essentially equivalent to a purchase by the lessee if it meets the following criteria:

1. Ownership of the asset is transferred to the lessee at the end of the lease term;
2. The lease contains a bargain purchase option to buy the equipment at less than fair market value;
3. The lease term equals or exceeds 75% of the asset's estimated useful life;
4. The present value of the lease payments equals or exceeds 90% of the total original cost of the equipment.

S Biomedics Co Long-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of S Biomedics Co's Long-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

S Biomedics Co (XKRX:304360) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » S Biomedics Co Ltd (XKRX:304360) » Definitions » Long-Term Capital Lease Obligation

Comparable Companies

Traded in Other Exchanges

N/A

Address

Seongsui-ro 26-gil, 4th Floor, Wooil Venture Town Building 28, Seongdong-gu, FedEx building, Seoul, KOR, 04797

Website

https://www.sbiomedics.com

S Biomedics Co Ltd researches and develops cell therapies for regenerative biomedicine. It owns two platform technologies: Functionally Enhanced Cell Spheroid and Targeted Embryonic Stem Cell Differentiation for developing cell therapy products that overcome the limitations of existing cell therapy products.

S Biomedics Co (XKRX:304360) Headlines

No Headlines